Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents

Khan, 2017, Synthesis, molecular docking with COX 1 & II enzyme, ADMET screening and in vivo anti-inflammatory activity of oxadiazole, thiadiazole and triazole analogues of felbinac, J Saudi Chem Soc, 1 Firke, 2015, Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzene sulphonamide as selective COX-2 inhibitors and anti-inflammatory agents, Bioorg Med Chem, 23, 5273, 10.1016/j.bmc.2015.07.070 Zidar, 2009, Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase, J Cell Mol Med, 13, 3755 Botting, 2006, Cyclooxygenase: past, present and future, J Therm Biol, 31, 208, 10.1016/j.jtherbio.2005.11.008 Naesdal, 2006, NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options, Drug Saf, 29, 119, 10.2165/00002018-200629020-00002 Cryer, 2005, NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality, Am J Gastroenterol, 100, 1694, 10.1111/j.1572-0241.2005.50565.x Lazzaroni, 2004, Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations, Pharmacol Ther, 20, 48 Adebayo, 2006, Is non-steroidal anti-inflammatory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?, Postgrad Med J, 82, 186, 10.1136/pgmj.2005.039586 Schneider, 2006, Association of selective and conventional non-steroidal anti-inflammatory drugs with acute renal failure: a population-based, nested case-control analysis, Am J Epidemiol, 164, 881, 10.1093/aje/kwj331 Mounier, 2006, Severe renal adverse events with aryl carboxylic non-steroidal anti- inflammatory drugs: results of an eight-year French national survey, Therapie, 61, 255 Dogne, 2005, Adverse cardiovascular effects of the coxibs, J Med Chem, 48, 2251, 10.1021/jm0402059 Abdellatif, 2006, Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors, Bioorg Med Chem Lett, 26, 406, 10.1016/j.bmcl.2015.11.105 Pilli, 1994, 6-Acyl-2-benzoxazolinone-3-yl-acetamide and aceto-nitrile derivatives with analgesic activities, Pharmazie, 49, 63 Paramashivappa, 2003, Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivative as cyclooxygenase inhibitors, Bioorg Med Chem Lett, 13, 657, 10.1016/S0960-894X(02)01006-5 Sondi, 2006, Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff’s bases, Bioorg Med Chem, 14, 5850 Ampati, 2010, Synthesis and in vitro evaluation of novel benzoxazole derivatives as specific cyclooxygenase – 2 inhibitors, J Chem Pharm Res, 2, 213 Chakraborti, 2014, 2-(2-Arylphenyl) benzoxazole as a novel anti-inflammatory scaffold: synthesis and biological evaluation, Med Chem Lett, 5, 512, 10.1021/ml400500e Sener, 2002, Synthesis and microbiological activity of some novel N-[2-(p-substituted phenyl)-5-benzoxazolyl] cyclohexylcarboxamide, cyclohexylacetamide and cyclohexylpropionamide derivatives, Farmaco, 57, 771, 10.1016/S0014-827X(02)01278-8 Yildiz, 2004, Synthesis and antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino] benzoxazoles, Arch Pharm, 337, 402, 10.1002/ardp.200300851 Gadegoni, 2013, Synthesis and screening of some novel 2-[5-(substituted phenyl)-[1,3,4]oxadiazol-2-yl]-benzoxazoles as potential antimicrobial agents, J Korean Chem Soc, 57, 221, 10.5012/jkcs.2013.57.2.221 Kim, 2010, Synthesis of benzoxazole amides as novel antifungal agents against Malassezia furfur, Bull Korean Chem Soc, 31, 1270, 10.5012/bkcs.2010.31.5.1270 Siddiqui, 2008, Synthesis, anticonvulsant and neurotoxicity evaluation of 5-carbomethoxybenzoxazole derivatives, Acta Polo Pharm Drug Res, 65, 449 Chatpalliwar, 2008, Synthesis and screening of some new 2-(3H)-benzoxazolone derivatives for analgesic, anti-inflammatory, and skeletal muscle relaxant activity, Indian J Heterocycl Chem, 17, 343 Safak, 1992, Synthesis of 3-(2-pyridylethyl) benzoxazolinone derivatives: potent analgesic and anti-inflammatory compounds inhibiting prostaglandin E2, J Med Chem, 135, 1296, 10.1021/jm00085a018 Seth, 2014, 2-(2-Arylphenyl) benzoxazole as a novel anti-inflammatory scaffold:synthesis and biological evaluation, ACS Med Chem Lett, 5, 512, 10.1021/ml400500e Kumar, 2012, Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors, J Mol Model, 18, 1791, 10.1007/s00894-011-1195-0 Kumar, 2016, Insights into the structural requirements of PKCβII inhibitors based on HQSAR and CoMSIA analyses, Chem Biol Drug Des, 78, 283, 10.1111/j.1747-0285.2011.01144.x Kumar, 2012, In silico identification of genetically attenuated vaccine candidate genes for Plasmodium liver stage, Infect Genet Evol, 36, 72, 10.1016/j.meegid.2015.09.002 Kumar, 2017, Synthesis, molecular docking and biological evaluation of bis-pyrimidine Schiff base derivatives, Chem Cent J, 11, 1 Cioli, 1979, The role of direct tissue contact in the production of gastro-intestinal ulcer by anti-inflammatory drugs in rats, Toxicol Appl Pharmacol, 50, 283, 10.1016/0041-008X(79)90153-4 Sievers, 2011, Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega, Mol Syst Biol, 7, 1, 10.1038/msb.2011.75 Consalvi, 2015, Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetate as potent COX-2 inhibitors, Bioorg Med Chem Lett, 23, 810, 10.1016/j.bmc.2014.12.041 Winter, 1962, Carragenan-induced edema in hind paws of the rat as an assay for anti-inflammatory drugs, Proc Soc Exp Boil, 111, 544, 10.3181/00379727-111-27849 Salentin, 2015, PLIP: fully automated protein-ligand interaction profiler, Nucl Acids Res, 43, 443, 10.1093/nar/gkv315 Bekhit, 2017, Synthesis, evaluation and mdellind of some triazolothienopyrimidinones anti-inflammatory and antimicrobial agents, Future Med Chem, 881, 10.4155/fmc-2016-0242 2014 Sharma, 2016, Structural insight into selective phosphodiestrase 4B inhibitor: pharmacophore-based virtual screening, docking and molecular dynamics simulations, J Biomol Struct Dyn, 35, 1339, 10.1080/07391102.2016.1183520 Sharma, 2016, Pharmacophore generation and atom based 3D-QSAR of quinolone derivatives as selective phosphodiestrase 4B inhibitors, RSC Adv, 6, 75805, 10.1039/C6RA11210B Patel, 2014, Synthesis, in vitro evaluation, and molecular docking studies of azetidinones and thiazolidinones of 2-amno-5-cyclopropyl-1,3,4-thidiazole as antibacterial agents, Arch Pharm, 347, 668, 10.1002/ardp.201400140 Zheng, 2008, (3S)-N-(1-Aminoacyl)-1,2,3,4-tetrahydroisoquinolines, a class of novel antithrombotic agents: synthesis, bioassay, 3D QSAR, and ADME analysis, Bioorg Med Chem, 16, 9574, 10.1016/j.bmc.2008.09.019 Gleeson, 2011, In-silico ADME models: a general assessment of their utility in drug discovery applications, Curr Top Med Chem, 11, 358, 10.2174/156802611794480927 Yamashita, 2004, In-silico approaches for predicting ADME properties of drugs, Drug Metab Phamaokinet, 19, 327, 10.2133/dmpk.19.327 Lipinski, 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv Drug Deliv Rev, 23, 4, 10.1016/S0169-409X(96)00423-1 Volpe, 2011, Drug-permeability and transporter assays in Caco-2 and MDCK cell lines, Future Med Chem, 3, 2063, 10.4155/fmc.11.149 Priest, 2008, Role of HERG potassium channel assays in drug development, Channels (Austin), 2, 87, 10.4161/chan.2.2.6004